Insider Transactions Reported by 15 Insiders of Satsuma Pharmaceuticals, Inc.

Location
Durham, NC

There are no Buy or Sell transactions made by insiders since 10 Feb 2025

Satsuma Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ken Takanashi Director, 10%+ Owner $22,611,402 06 Jun 2023
Shin Nippon Biomedical Laboratories, Ltd. 10%+ Owner $9,995,906 06 Jun 2023
Braden M Leonard 10%+ Owner $5,996,900 21 Nov 2022
Commodore Capital LP 10%+ Owner $325,668 14 Nov 2022
DETLEF ALBRECHT Chief Medical Officer 03 Jun 2022
Heath Lukatch Director 08 Jun 2023
RA CAPITAL MANAGEMENT, L.P. Former 10% Owner 08 Jun 2023
Thomas P. Soloway Director 08 Jun 2023
THOMAS BRAXTON KING Director 08 Jun 2023
Rajeev M. Shah Director, 10%+ Owner 06 Jun 2023
John A. Kollins President and CEO, Director 06 Jun 2023
Mutya Harsch Director 08 Jun 2023
Thomas P. O'Neil Chief Financial Officer 06 Jun 2023
Michael T. Riebe Director 08 Jun 2023
Elisabeth Sandoval Little Director 08 Jun 2023

Recent Insider Transactions by Companies or Individuals for Satsuma Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.